Lansoprazole Dr Capsule, Delayed Release
Product Images NDC 72189-370

2 FDA label images from Direct_rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole Dr (NDC 72189-370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct_rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72189-0370-90 (72189 0370 90)

72189-0370-90 (72189 0370 90)
Lansoprazole DR 30 mg capsule, delayed release, 90 count, labeled by Direct Rx. The label highlights it as a generic equivalent to Prevacid, containing 30 mg of lansoprazole USP as enteric-coated pellets. The label shows lot number, expiration date 12/31/23, packaging details, and manufacturer information including NDC codes and manufacturing lot numbers.*
FDA Label Image

72189-370-30 (72189 370 30)

72189-370-30 (72189 370 30)
Lansoprazole DR 30 mg delayed-release capsules label from Direct Rx. The label indicates 30 capsules per package and states the generic is for Prevacid. It includes manufacturing and expiration details, lot number 23MY2411, and the product NDC 72189-370-30. The packaging directs to store between 68-77 degrees Fahrenheit and keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.